VYNE - Foamix Pharmaceuticals Ltd (FOMX) CEO Dave Domzalski on Q4 2020 Results - Earnings Call Transcript
Foamix Pharmaceuticals Ltd (FOMX) Q4 2020 Earnings Conference Call March 4, 2021 08:30 ET Company Participants Michael Wood - Investor Relations Dave Domzalski - President and Chief Executive Officer Matt Wiley - Chief Commercial Officer Andrew Saik - Chief Financial Officer Iain Stuart - Chief Scientific Officer Conference Call Participants Carvey Leung - Cantor Fitzgerald David Amsellem - Piper Sandler Balaji Prasad - Barclays Patrick Dolezal - LifeSci Capital Oren Livnat - H.C. Wainwright Tim Chiang - Northland Securities Presentation Operator Good morning and welcome to the VYNE Therapeutics Conference Call to discuss the Fourth Quarter and Full Year 2020 Financial Results and Update. [Operator Instructions] Following the company’s formal remarks, we will open the call for your questions. Please be advised that this call is being recorded at the company’s request. I will now turn the call over to Michael Wood of LifeSci Advisors. Please go ahead. Michael Wood
For further details see:
Foamix Pharmaceuticals Ltd (FOMX) CEO Dave Domzalski on Q4 2020 Results - Earnings Call Transcript